GBS Inc. Logo

GBS Inc.

GBS

(1.2)
Stock Price

0,47 USD

-378.56% ROA

-415.56% ROE

-0.03x PER

Market Cap.

433.577,00 USD

32.95% DER

0% Yield

-699.09% NPM

GBS Inc. Stock Analysis

GBS Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

GBS Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.09x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (28%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-119.1%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-156.74%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

GBS Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

GBS Inc. Technical Stock Analysis
# Analysis Recommendation

GBS Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

GBS Inc. Revenue
Year Revenue Growth
2018 0
2019 0 0%
2020 0 0%
2021 1.980.484 100%
2022 437.146 -353.05%
2023 1.256.872 65.22%
2024 3.056.252 58.88%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

GBS Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2018 2.525.798
2019 3.179.864 20.57%
2020 588.206 -440.6%
2021 3.835.703 84.66%
2022 3.853.919 0.47%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

GBS Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 2.077.669
2019 3.549.861 41.47%
2020 2.428.358 -46.18%
2021 3.718.263 34.69%
2022 4.920.103 24.43%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

GBS Inc. EBITDA
Year EBITDA Growth
2018 -4.566.511
2019 -6.671.846 31.56%
2020 -2.676.857 -149.24%
2021 -5.943.678 54.96%
2022 -8.298.512 28.38%
2023 -13.561.965 38.81%
2024 -9.126.680 -48.6%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

GBS Inc. Gross Profit
Year Gross Profit Growth
2018 0
2019 0 0%
2020 0 0%
2021 1.980.484 100%
2022 437.146 -353.05%
2023 326.668 -33.82%
2024 796.992 59.01%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

GBS Inc. Net Profit
Year Net Profit Growth
2018 -5.020.383
2019 -7.336.686 31.57%
2020 -3.134.602 -134.05%
2021 -7.037.286 55.46%
2022 -8.295.612 15.17%
2023 -10.631.720 21.97%
2024 -7.878.564 -34.94%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

GBS Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 -1 0%
2020 0 0%
2021 -1 0%
2022 -1 0%
2023 -11 100%
2024 -8 -25%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

GBS Inc. Free Cashflow
Year Free Cashflow Growth
2018 -5.384.655
2019 -5.577.184 3.45%
2020 -498.618 -1018.53%
2021 -11.296.477 95.59%
2022 -3.738.255 -202.19%
2023 -7.377.378 49.33%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

GBS Inc. Operating Cashflow
Year Operating Cashflow Growth
2018 -5.384.655
2019 -5.577.184 3.45%
2020 -498.618 -1018.53%
2021 -11.296.477 95.59%
2022 -3.358.034 -236.4%
2023 -7.377.378 54.48%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

GBS Inc. Capital Expenditure
Year Capital Expenditure Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 380.221 100%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

GBS Inc. Equity
Year Equity Growth
2018 -4.375.469
2019 -4.615.057 5.19%
2020 -5.186.517 11.02%
2021 15.006.621 134.56%
2022 6.545.771 -129.26%
2023 3.686.998 -77.54%
2024 3.154.234 -16.89%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

GBS Inc. Assets
Year Assets Growth
2018 2.495.923
2019 2.327.950 -7.22%
2020 2.475.640 5.97%
2021 21.859.369 88.67%
2022 12.352.173 -76.97%
2023 10.354.612 -19.29%
2024 8.826.992 -17.31%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

GBS Inc. Liabilities
Year Liabilities Growth
2018 5.559.617
2019 6.305.088 11.82%
2020 7.690.468 18.01%
2021 6.852.748 -12.22%
2022 5.806.402 -18.02%
2023 6.667.614 12.92%
2024 5.672.758 -17.54%

GBS Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.26
Net Income per Share
-15.82
Price to Earning Ratio
-0.03x
Price To Sales Ratio
0.2x
POCF Ratio
-0.08
PFCF Ratio
-0.08
Price to Book Ratio
0.14
EV to Sales
0.18
EV Over EBITDA
-0.03
EV to Operating CashFlow
-0.07
EV to FreeCashFlow
-0.07
Earnings Yield
-33.43
FreeCashFlow Yield
-12.67
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
35.06
Graham NetNet
-4.09

Income Statement Metrics

Net Income per Share
-15.82
Income Quality
0.52
ROE
-4.16
Return On Assets
-1.7
Return On Capital Employed
-3.78
Net Income per EBT
1.12
EBT Per Ebit
0.97
Ebit per Revenue
-6.4
Effective Tax Rate
-0.12

Margins

Sales, General, & Administrative to Revenue
1.72
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0.12
Gross Profit Margin
0.09
Operating Profit Margin
-6.4
Pretax Profit Margin
-6.23
Net Profit Margin
-6.99

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-6.29
Free CashFlow per Share
-5.79
Capex to Operating CashFlow
-0.08
Capex to Revenue
0.22
Capex to Depreciation
0.28
Return on Invested Capital
-3.19
Return on Tangible Assets
-3.79
Days Sales Outstanding
44.64
Days Payables Outstanding
0
Days of Inventory on Hand
176.68
Receivables Turnover
8.18
Payables Turnover
0
Inventory Turnover
2.07
Capex per Share
0.5

Balance Sheet

Cash per Share
1,18
Book Value per Share
3,45
Tangible Book Value per Share
-1.79
Shareholders Equity per Share
3.45
Interest Debt per Share
0.91
Debt to Equity
0.33
Debt to Assets
0.12
Net Debt to EBITDA
0
Current Ratio
0.57
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.33
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.55
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
953570.5
Debt to Market Cap
2.49

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

GBS Inc. Dividends
Year Dividends Growth

GBS Inc. Profile

About GBS Inc.

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

CEO
Mr. Harry Simeonidis
Employee
12
Address
708 3rd Avenue
New York, 10019

GBS Inc. Executives & BODs

GBS Inc. Executives & BODs
# Name Age
1 Mr. Harry Simeonidis
Pres of Asia Pacific
70
2 Ms. Victoria Gavrilenko
Operations Mang.
70
3 Mr. Alex Arzeno
Vice President of Investor Relations
70
4 Dr. Stephen Constantine Boyages M.D., MBBS, Ph.D.
Interim Chief Executive Officer & Chairman
70
5 Mr. Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law
Chief Financial Officer
70

GBS Inc. Competitors